Vaccine makers and liability protection: Laughing all the way to the bank – conflicts of interest undermine Children’s Health by Erin Elizabeth for Health Nut News
By the Children’s Health Defense Team
[Note: This is Part III in a series of articles adapted from the second Children’s Health Defense eBook: Conflicts of Interest Undermine Children’s Health. The first eBook, The Sickest Generation: The Facts Behind the Children’s Health Crisis and Why It Needs to End, described how children’s health began to worsen dramatically in the late 1980s following fateful changes in the childhood vaccine schedule.]
“…the unprecedented health crisis beleaguering American children began around the same time that Congress passed the National Childhood Vaccine Injury Act.”
When it comes to telling the story of vaccine injuries and how frighteningly commonplace they have become, denial, censorship and lies seem to be ruling the day—for now. However, future public health historians will surely acknowledge that the unprecedented health crisis beleaguering American children began around the same time—1986—that Congress let the genie out of the bottle by passing the National Childhood Vaccine Injury Act (NCVIA).
While the Act marked a depressing turning point for American children and their families, it was a bonanza for the pharmaceutical industry. The industry protections offered by the Act—which essentially awarded vaccine makers blanket immunity from liability for injuries resulting from childhood vaccines, “no matter how toxic the ingredients, how negligent the manufacturer or how grievous the harm”—sparked a gold rush of vaccine development.
“By the close of 2017, analysts valued the highly consolidated global pharmaceutical market at over $1.1 trillion (U.S. dollars).”
The big four
The Act’s banishment of liability as a business worry catapulted vaccines from a “neglected corner of the drugs business” into a major economic driver of the medical and pharmaceutical industries. In the U.S., four companies have been the principal beneficiaries of the no-liability business environment for childhood vaccines. The four pharmaceutical giants—GlaxoSmithKline (GSK), Merck, Pfizer and Sanofi Pasteur—manufacture every vaccine on the U.S. childhood schedule. In addition to the “big four,” companies such as Seqirus and MedImmune (AstraZeneca) have been crowding into the increasingly lucrative adult vaccine market.